Cardiovascular risk reduction following diagnosis of diabetes by screening: 1-year results from the ADDITION-Cambridge trial cohort.

PubWeight™: 0.82‹?›

🔗 View Article (PMC 3361118)

Published in Br J Gen Pract on June 01, 2012

Authors

Morten Charles1, Rebecca K Simmons, Kate M Williams, Gojka Roglic, Stephen J Sharp, Ann-Louise Kinmonth, Nicholas J Wareham, Simon J Griffin

Author Affiliations

1: Section of General Practice, Department of Public Health, Faculty of Health Sciences, Aarhus University, Denmark.

Articles cited by this

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med (1998) 46.95

10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med (2008) 35.49

Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ (1998) 32.73

Health inequalities among British civil servants: the Whitehall II study. Lancet (1991) 24.79

Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med (2003) 20.06

Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med (2008) 18.27

The effect of race and sex on physicians' recommendations for cardiac catheterization. N Engl J Med (1999) 17.75

Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med (2006) 16.17

Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care (2007) 14.35

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. Lancet (2000) 13.71

MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Lancet (2003) 13.69

Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med (2010) 8.77

Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) Diabetes Care (1997) 7.85

The stigma of obesity: a review and update. Obesity (Silver Spring) (2009) 7.80

Differences in control of cardiovascular disease and diabetes by race, ethnicity, and education: U.S. trends from 1999 to 2006 and effects of medicare coverage. Ann Intern Med (2009) 6.33

Physical activity/exercise and type 2 diabetes: a consensus statement from the American Diabetes Association. Diabetes Care (2006) 4.52

Diet or diet plus physical activity versus usual care in patients with newly diagnosed type 2 diabetes: the Early ACTID randomised controlled trial. Lancet (2011) 4.35

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet (2011) 4.15

The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord (2000) 3.83

Validation of dietary assessment methods in the UK arm of EPIC using weighed records, and 24-hour urinary nitrogen and potassium and serum vitamin C and carotenoids as biomarkers. Int J Epidemiol (1997) 3.79

Should we screen for type 2 diabetes? Evaluation against National Screening Committee criteria. BMJ (2001) 3.48

Validity and repeatability of the EPIC-Norfolk Physical Activity Questionnaire. Int J Epidemiol (2002) 3.38

Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ (2001) 3.12

Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer--Norfolk prospective study. Arch Intern Med (2008) 2.71

Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study. Br J Gen Pract (2009) 2.40

Age-associated cardiovascular changes in health: impact on cardiovascular disease in older persons. Heart Fail Rev (2002) 2.29

Body weight and health care among women in the general population. Arch Fam Med (1998) 2.26

Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care (2010) 2.15

Use of statins in the secondary prevention of coronary heart disease: is treatment equitable? Heart (2002) 1.98

The ADDITION-Cambridge trial protocol: a cluster -- randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients. BMC Public Health (2009) 1.83

Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care (2008) 1.70

Gender-specific care of the patient with diabetes: review and recommendations. Gend Med (2006) 1.59

Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes. Diabetes Care (2008) 1.51

What determines the cost-effectiveness of diabetes screening? Diabetologia (2006) 1.51

Who attends a UK diabetes screening programme? Findings from the ADDITION-Cambridge study. Diabet Med (2010) 1.48

Screening for Type 2 diabetes--should it be now? Diabet Med (2003) 1.14

Evidence for inequalities in the management of coronary heart disease in Scotland. Heart (2005) 1.10

Differences in cardiovascular disease risk factor management in primary care by sex of physician and patient. Ann Fam Med (2010) 1.05

A study of discrimination within the medical community as viewed by obese patients. Obes Surg (2002) 0.94

Adherence to guidelines in people with screen-detected type 2 diabetes, ADDITION, Denmark. Scand J Prim Health Care (2009) 0.93

Fitness, fatness, and systolic blood pressure: data from the Cooper Center Longitudinal Study. Am Heart J (2010) 0.86

Articles by these authors

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care (2004) 75.82

A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science (2007) 37.88

Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes. Nat Genet (2008) 35.06

Biological, clinical and population relevance of 95 loci for blood lipids. Nature (2010) 28.21

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation. Nat Genet (2008) 22.35

Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature (2010) 20.01

New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet (2010) 17.89

Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet (2010) 16.96

Genome-wide association analysis identifies 20 loci that influence adult height. Nat Genet (2008) 16.92

Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet (2008) 15.94

Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature (2011) 13.25

Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet (2009) 12.44

Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet (2012) 11.09

Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. BMJ (2007) 11.09

Variants in MTNR1B influence fasting glucose levels. Nat Genet (2008) 10.85

The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet (2008) 9.03

Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet (2010) 8.89

Meta-analysis and imputation refines the association of 15q25 with smoking quantity. Nat Genet (2010) 8.55

Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet (2010) 7.94

Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet (2012) 6.81

Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat Genet (2010) 6.66

LDL-cholesterol concentrations: a genome-wide association study. Lancet (2008) 6.44

C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39

Effectiveness of interventions to promote physical activity in children and adolescents: systematic review of controlled trials. BMJ (2007) 6.30

Genome-wide association scan meta-analysis identifies three Loci influencing adiposity and fat distribution. PLoS Genet (2009) 5.81

Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet (2012) 4.73

Effectiveness of physical activity promotion based in primary care: systematic review and meta-analysis of randomised controlled trials. BMJ (2012) 4.46

A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance. Nat Genet (2012) 4.37

Meta-analysis of genome-wide scans for human adult stature identifies novel Loci and associations with measures of skeletal frame size. PLoS Genet (2009) 4.24

Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial. Lancet (2011) 4.15

Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health (2007) 4.13

Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility. Nat Genet (2014) 4.13

Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes (2008) 4.11

Genome-wide association study identifies five loci associated with lung function. Nat Genet (2009) 4.10

Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol (2010) 4.08

Common variants at 10 genomic loci influence hemoglobin A₁(C) levels via glycemic and nonglycemic pathways. Diabetes (2010) 4.07

A causal modelling approach to the development of theory-based behaviour change programmes for trial evaluation. Health Educ Res (2005) 4.06

Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children. PLoS Med (2011) 3.94

Lipid-related markers and cardiovascular disease prediction. JAMA (2012) 3.91

Combined effect of health behaviours and risk of first ever stroke in 20,040 men and women over 11 years' follow-up in Norfolk cohort of European Prospective Investigation of Cancer (EPIC Norfolk): prospective population study. BMJ (2009) 3.89

Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. N Engl J Med (2016) 3.88

Interventions to promote cycling: systematic review. BMJ (2010) 3.85

Effect on health-related outcomes of interventions to alter the interaction between patients and practitioners: a systematic review of trials. Ann Fam Med (2004) 3.84

An implementation research agenda. Implement Sci (2009) 3.77

Genetic loci influencing kidney function and chronic kidney disease. Nat Genet (2010) 3.75

Cell-specific protein phenotypes for the autoimmune locus IL2RA using a genotype-selectable human bioresource. Nat Genet (2009) 3.59

Common variants in WFS1 confer risk of type 2 diabetes. Nat Genet (2007) 3.58

A family with severe insulin resistance and diabetes due to a mutation in AKT2. Science (2004) 3.54

Branched equation modeling of simultaneous accelerometry and heart rate monitoring improves estimate of directly measured physical activity energy expenditure. J Appl Physiol (1985) (2003) 3.50

Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure. Nat Genet (2011) 3.40

Thirty new loci for age at menarche identified by a meta-analysis of genome-wide association studies. Nat Genet (2010) 3.37

Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31

Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat Genet (2013) 3.25

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours. Cochrane Database Syst Rev (2010) 3.25

Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet (2012) 3.21

Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat Genet (2011) 3.18

Features of the metabolic syndrome are associated with objectively measured physical activity and fitness in Danish children: the European Youth Heart Study (EYHS). Diabetes Care (2004) 3.15

New gene functions in megakaryopoiesis and platelet formation. Nature (2011) 3.14

Genetic variation in LIN28B is associated with the timing of puberty. Nat Genet (2009) 3.09

Physical activity and dietary behaviour in a population-based sample of British 10-year old children: the SPEEDY study (Sport, Physical activity and Eating behaviour: environmental Determinants in Young people). BMC Public Health (2008) 3.09

Genome-wide association analyses identify 18 new loci associated with serum urate concentrations. Nat Genet (2012) 3.04

Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet (2011) 3.03

Hierarchy of individual calibration levels for heart rate and accelerometry to measure physical activity. J Appl Physiol (1985) (2007) 2.99

Efficacy of a theory-based behavioural intervention to increase physical activity in an at-risk group in primary care (ProActive UK): a randomised trial. Lancet (2008) 2.98

Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet (2013) 2.92

Primary care research networks in the United Kingdom. BMJ (2007) 2.83

Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits. PLoS Genet (2013) 2.83

Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ (2011) 2.77

Seventy-five genetic loci influencing the human red blood cell. Nature (2012) 2.77

FTO genotype is associated with phenotypic variability of body mass index. Nature (2012) 2.77

Cumulative effects and predictive value of common obesity-susceptibility variants identified by genome-wide association studies. Am J Clin Nutr (2009) 2.74

Temporal trends in physical activity in England: the Health Survey for England 1991 to 2004. Prev Med (2007) 2.73

Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile. Nat Genet (2011) 2.73

Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts. PLoS Med (2013) 2.73

Assessment of physical activity in youth. J Appl Physiol (1985) (2008) 2.71

Plasma vitamin C level, fruit and vegetable consumption, and the risk of new-onset type 2 diabetes mellitus: the European prospective investigation of cancer--Norfolk prospective study. Arch Intern Med (2008) 2.71

Criterion-related validity of the last 7-day, short form of the International Physical Activity Questionnaire in Swedish adults. Public Health Nutr (2006) 2.70

CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70

Associations between exposure to takeaway food outlets, takeaway food consumption, and body weight in Cambridgeshire, UK: population based, cross sectional study. BMJ (2014) 2.69

Estimating the population impact of screening strategies for identifying and treating people at high risk of cardiovascular disease: modelling study. BMJ (2010) 2.68

Estimating physical activity energy expenditure, sedentary time, and physical activity intensity by self-report in adults. Am J Clin Nutr (2009) 2.68

High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies. J Am Coll Cardiol (2008) 2.51

Beyond low-density lipoprotein cholesterol: respective contributions of non-high-density lipoprotein cholesterol levels, triglycerides, and the total cholesterol/high-density lipoprotein cholesterol ratio to coronary heart disease risk in apparently healthy men and women. J Am Coll Cardiol (2009) 2.50

Time spent being sedentary and weight gain in healthy adults: reverse or bidirectional causality? Am J Clin Nutr (2008) 2.49

Targeting sedentary time or moderate- and vigorous-intensity activity: independent relations with adiposity in a population-based sample of 10-y-old British children. Am J Clin Nutr (2009) 2.49